In a recent study published in the Journal of Infection, researchers performed a systematic literature review of global treatment outcomes of extensively drug-resistant Tuberculosis. The study found ...

Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash ...

We enrolled 41 patients who had sputum-culture–positive extensively drug-resistant (XDR) tuberculosis and who had not had a response to any available chemotherapeutic option during the previous 6 ...

Only four out of 10 patients with extensively drug-resistant tuberculosis (TB) in Europe achieved successful treatment outcomes, a rate markedly lower than that for other forms of drug-resistant TB ...

Strains of tuberculosis (TB) that are resistant to both first-line and second-line drugs could threaten the success of not only tuberculosis programs, but also HIV treatment programs worldwide, ...

February 26, 2009 – (BRONX, NY) – A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating extensively drug resistant ...

There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

Please provide your email address to receive an email when new articles are posted on . In February, the CDC published a health advisory via the Health Alert Network to bring more attention to this ...

WASHINGTON (Reuters) - The hardest-to-treat form of tuberculosis kills half the people who get it, according to a South Korean study that is one of the few to track survival rates from the condition ...

Behind the county hospital’s tall cinderblock walls, a 27-year-old tuberculosis patient sits in a jail cell equipped with a ventilation system that keeps germs from escaping. Robert Daniels has been ...